Qube Research & Technologies (QRT)’s Vigil Neuroscience VIGL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-536,256	Closed	-$4.26M	–	3978
2025 Q2	$4.26M	Buy	536,256 +504,686	+1,599%	+$2.26M	﹤0.01%	1804
2025 Q1	$56.2K	Sell	31,570 -76,912	-71%	-$173K	﹤0.01%	3104
2024 Q4	$184K	Buy	108,482 +65,897	+155%	+$195K	﹤0.01%	2853
2024 Q3	$145K	Buy	42,585 +12,156	+40%	+$45K	﹤0.01%	2679
2024 Q2	$122K	Buy	+30,429	New	+$104K	﹤0.01%	2555
2023 Q2	–	Sell	-18,705	Closed	-$183K	–	3064
2023 Q1	$183K	Buy	+18,705	New	+$210K	﹤0.01%	1960

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VIGL Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 536,256 shares — an estimated $4.26M sold.

Qube Research & Technologies (QRT) first reported a position in VIGL in Q1 2023 and held it in 6 quarters. The position peaked at $4.26M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Qube Research & Technologies (QRT) reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 536,256 Vigil Neuroscience shares in Q3 2025, an estimated $4.26M.
Qube Research & Technologies (QRT) first reported a position in Vigil Neuroscience in Q1 2023 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Vigil Neuroscience position peaked at $4.26M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.